Agendia will present new data from ongoing clinical research evaluating the combination of MammaPrint and BluePrint genomic tests.

The data, which builds upon existing clinical research that demonstrates the efficacy of MammaPrint and BluePrint testing to support treatment planning decisions, highlights Agendia’s ongoing trials that have the potential to impact patient treatment and outcomes.

We invite you to meet our team via live chat. We can discuss genomic testing in the pre-operative setting, or answer any questions you might have.

Agendia’s activities at SG-BCC2021:

Data Highlights

P111 | Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens.

P088 | 5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial

P112 | MammaPrint, BluePrint, and full-genome data linked with clinical data to evaluate new gene EXpression profiles (FLEX): a real-world dataset and investigator-initiated protocols in ESBC.

More Information below.

#IAMHERE

An intimate portrait series that illustrates the essence of 50 people who have been touched by breast cancer – Click here to view campaign.

Virtual Booth

Visit our virtual booth for more information and to speak with a member of our team.

How to Register:

Dr. M. Kleijn

Title: Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
Number: P111 in e-poster gallery. Please contact the author via the meeting hub.
Authors: M. Kleijn*, J. McKelley, J. Wei, B. Hoxeng, A. Menicucci, S. Wang, T. van Dalen, H. Horlings, W. Audeh
* Medical and Clinical Affairs, Agendia, N.V., Amsterdam, Netherlands

©NFP-170180-236HRgroot-e1498468185480-250×250 (1)

Dr. E. Göker

Title: 5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial
Number: P088 in e-poster gallery. Please contact the author via the meeting hub.
Authors: E. Göker*, M.P. Hendriks , M. van Tilburg, Andrei Barcaru, Lorenza Mittempergher, A. van Egmond , M. Kleijn and D. Generali
* Alexander Monro Ziekenhuis , Bilthoven , the Netherlands

Dr. J. Crozier

Title: MammaPrint, BluePrint, and full-genome data linked with clinical data to evaluate new gene EXpression profiles (FLEX): a real-world dataset and investigator-initiated protocols in ESBC.
Number: P112 in e-poster gallery. Please contact the author via the meeting hub.
Authors: Jennifer A. Crozier*, Lisa Blumencranz, Miranda Kleijn, Heather Kling, Amy M. Truitt, Darina Pronin, Christine Finn, William Audeh, Bastiaan van der Baan, FLEX Investigators Group
* Baptist MD Anderson Cancer Center, Jacksonville, FL,USA

FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Landmark Trials

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

See the mindact trial

AGENDIA AT ST. GALLEN